JAK inhibitor BMS-911543, Purity ≥98%

Cat. No.: X23-10-ZQ362

JAK inhibitor BMS-911543, Purity ≥98%

Synonym: BMS-911543; 1271022-90-2; BMS911543; BMS 911543; N,N-Dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide; JAK inhibitor

  • MDL: MFCD22200575
  • CAS Number: 1271022-90-2
  • Compound CID: 50922691
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMS-911543, soluble in DMSO and ethanol and insoluble in water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, SET-2, and Tyk2.
Molecular Weight
432.52
Molecular Formula
C23H28N8O
Targets
JAK1: 360 nM; JAK2: 1.1 nM; JAK3: 75 nM; SET-2: 60 nM; Tyk2: 66 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 36 mg/mL (83.23 mM); Water: Insoluble; Ethanol: 22 mg/mL (50.86 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BMS-911543 is used to explore its ability to inhibit JAK2 and its potential therapeutic applications in myeloproliferative neoplasms.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.